Tea polyphenols, their biological effects and potential molecular targets

Area of Science:

• Nutritional Biochemistry
• Preventive Oncology
• Molecular Biology

Background:

• Tea, particularly green tea from Camellia sinensis, is globally popular and rich in polyphenols, especially (-)-epigallocatechin gallate (EGCG).
• Historically consumed for centuries, green tea is now extensively researched for its health-promoting properties, including disease and cancer prevention.

Purpose of the Study:

• To review the scientific evidence supporting green tea's role in preventing chronic diseases and cancers.
• To explore the molecular mechanisms and biological pathways targeted by green tea polyphenols in cancer prevention.

Main Methods:

• Review of epidemiological, cell culture, animal, and clinical studies on green tea consumption and health outcomes.
• Analysis of in vitro and in vivo data on the effects of tea polyphenols on cellular processes and tumor development.
• Examination of findings from Phase I and II clinical trials investigating green tea's anticancer potential.

Main Results:

• Green tea consumption may modestly reduce cholesterol and prevent atherosclerosis.
• In vitro studies demonstrate tea polyphenols induce apoptosis and cell cycle arrest in tumor cells.
• Animal studies show green tea inhibits tumor incidence across various organs; human trials are exploring anticancer effects.

Conclusions:

• Green tea exhibits significant potential for cancer prevention, supported by diverse scientific evidence.
• Understanding molecular targets and biomarkers for tea polyphenols is crucial for advancing green tea-based cancer prevention strategies and clinical trials.